Specifically, the regulation of GLS2 mainly reverses mitophagy during the latent period of epilepsy by affecting the expression of PINK1, p62, LC3, and TOMM20, thereby reducing the occurrence of SLEs. Here, SQSTM1 is linked to epilepsy.